MARIZYME INC. MRZM news, videos and press releases
For more news please use our advanced search feature.
MARIZYME INC. MRZM - More news...
MARIZYME INC. MRZM - More news...
- Marizyme Enters Into Co-Development Agreement With Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft™
- Marizyme CEO Delivers Business Update
- Marizyme CEO Delivers Business Update
- InvestmentPitch Media Video Features Marizyme's CEO David Barthel Discussing Receipt of FDA Clearance for its Flagship DuraGraft Medical Device
- The Watchlist by The Market Herald Releases New Interviews with Marizyme, Regenx, BuildDirect, and Three Sixty Solar Discussing Their Latest News
- Marizyme, Inc. Announces FDA Clearance for Flagship Product, DuraGraft™
- Marizyme, Inc. Announces FDA Clearance for Flagship Product, DuraGraft™
- Marizyme, Inc.: Marizyme Announces IP Developments for DuraGraft® and its Pipeline of Products
- Marizyme Announces IP Developments for DuraGraft® and Its Pipeline Products
- Marizyme CEO Delivers Business Update
- Marizyme Announces Allowance of Patent Application for Flagship Product DuraGraft by United States Patent and Trademark Office
- Marizyme Announces the Closing of My Health Logic Acquisition Along With Initial Financing
- Marizyme Inc. Announces Results of GOAL Study Presented at 7th Annual International Coronary Congress
- Marizyme Announces Expansion of Patent Portfolio Into Several Key Territories
- Marizyme is Pleased to Announce the Appointment of David Barthel as CEO
- DGAP-News: Marizyme Announces European DuraGraft(R) Registry Results Presented at the European Association for Cardio-Thoracic Surgery (EACTS) 34th Annual Virtual Meeting
- Marizyme Signs LOI With Chromocell to Acquire or License Assets
- Marizyme, Inc. Receives FDA Feedback on Development Plan for Krillase(TM) in Pediatric Stroke